HUMINSULIN N (Insulin Isophane (100IU))

Huminsulin N 100IU/ml Injection is indicated for the management of blood glucose levels in individuals diagnosed with type 1 or type 2 diabetes mellitus, both in adults and children. This formulation is categorized as an intermediate-acting insulin, which plays a crucial role in lowering blood sugar levels and minimizing the risk of severe complications linked to diabetes. Typically, this medication may be utilized in combination with short-acting insulin or other oral hypoglycemic agents. It is essential that patients receive thorough instruction from a healthcare provider regarding the proper technique for subcutaneous administration of this medication. It is vital not to discontinue the use of this insulin without prior consultation with a healthcare professional. Huminsulin N should be incorporated into a comprehensive treatment plan that also emphasizes adherence to a balanced diet, routine physical activity, and weight management as recommended by a healthcare provider. Regular monitoring of blood glucose levels is imperative, allowing patients to track their results and communicate them with their healthcare practitioner effectively. This monitoring is significant for determining the appropriate dosage of insulin necessary for individual needs. The principal adverse effect associated with this medication is hypoglycemia, or low blood sugar levels. To mitigate this risk, it is crucial to strictly adhere to the prescribed dosage, maintain consistent meal patterns, and routinely check blood sugar levels. Excessive alcohol consumption can contribute to decreased blood sugar levels. Other potential side effects may include localized reactions at the injection site, such as redness or swelling. Frequent injection at the same site could lead to lipodystrophy, characterized by skin thickening or indentations where the insulin has been administered. Some patients may also experience weight gain or generalized edema due to fluid retention while on insulin therapy. Patients should avoid the use of this medication if they are experiencing hypoglycemia. It is important for individuals with a history of kidney, liver, or heart conditions to inform their healthcare provider prior to beginning treatment. Pregnant or lactating women should also seek medical advice to determine if any dosage adjustments are necessary.